Amyloid pathology and protein kinase C (PKC): Possible therapeutics effects of PKC activators

Ana Olariu, Kiyofumi Yamada, Toshitaka Nabeshima

研究成果: Review article

19 引用 (Scopus)

抜粋

Amyloid β-protein (Aβ) is one of the most studied peptides in human neurodegenerative disorders. Although much has been learned about the biochemistry of this peptide, fundamental questions such as when and how the Aβ becomes pathologic remain unanswered. In this article we review the recent findings on the biology and pathology of Aβ and the role protein kinase C (PKC) plays in these processes. The potential neuroprotective role of PKC and the possible therapeutic effects of PKC activators in Alzheimer's disease (AD) will be discussed. Briefly, comments will be also addressed on the role of PKC in cell death and neurogenesis in AD.

元の言語English
ページ(範囲)1-5
ページ数5
ジャーナルJournal of Pharmacological Sciences
97
発行部数1
DOI
出版物ステータスPublished - 01-01-2005
外部発表Yes

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

これを引用